Waters Corporation $WAT Shares Bought by Tema Etfs LLC

Key Points

• Tema Etfs LLC increased its stake in Waters Corporation by 103.6% in Q1, owning 2,816 shares worth $1,038,000 at the quarter's end.
• Waters reported earnings of $2.95 per share, exceeding estimates, with revenue of $771.33 million in the last quarter, up 8.8% year-over-year.
• Waters has a consensus rating of "Hold" from analysts, with an average price target of $378.73 per share.

Tema Etfs LLC raised its position in Waters Corporation (NYSE:WAT - Free Report) by 103.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,816 shares of the medical instruments supplier's stock after buying an additional 1,433 shares during the period. Tema Etfs LLC's holdings in Waters were worth $1,038,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Olde Wealth Management LLC purchased a new position in Waters in the first quarter valued at $25,000. Zions Bancorporation National Association UT purchased a new position in Waters in the first quarter valued at $28,000. IFP Advisors Inc increased its holdings in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock valued at $30,000 after buying an additional 44 shares in the last quarter. Whipplewood Advisors LLC increased its holdings in Waters by 5,200.0% in the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 104 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Waters in the first quarter valued at $41,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

Waters Price Performance

WAT traded up $4.24 on Friday, reaching $301.89. 721,655 shares of the company's stock were exchanged, compared to its average volume of 713,178. The stock has a market cap of $17.97 billion, a PE ratio of 27.22, a P/E/G ratio of 2.81 and a beta of 1.04. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The stock's fifty day moving average price is $309.86 and its 200-day moving average price is $338.42. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. The firm had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. Waters's quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business posted $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently issued reports on WAT. Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Waters and gave the company a "hold" rating in a research report on Tuesday, August 5th. Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Scotiabank reiterated a "sector outperform" rating and issued a $465.00 target price on shares of Waters in a research report on Friday, July 11th. Wall Street Zen lowered shares of Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Finally, UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.